Records containing: Neoplasm Metastasis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-11-27Dexamethasone as Palliative Treatment in Addition to Radiation Therapy for Patients With Brain Metastases: A Prospective Study
-
CLINICAL_TRIALS study record update · 2019-11-18A Phase 1a Multicenter, Open-label Safety, Tolerability and Pharmacokinetic Study of CC-90003, a Selective Extracellular Signal-Regulated Kinase (ERK) Inhibitor, in Subjects With Locally-Advanced or Metastatic, Relapsed, or Refractory BRAF or RAS-Mutated Malignancies
-
CLINICAL_TRIALS study record update · 2019-11-08Multicenter, Randomized, Double-blind, Placebo-controlled Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma Whose Disease Has Progressed on Treatment With DTIC, IL-2, or IFN Based Therapy
-
CLINICAL_TRIALS study record update · 2019-10-23A Phase 1 Study of LY3164530, a Bispecific Antibody Targeting Mesenchymal-Epithelial Transition Factor (MET) and Epidermal Growth Factor Receptor (EGFR), in Patients With Advanced or Metastatic Cancer
-
CLINICAL_TRIALS study record update · 2019-10-22The REPEAT Trial: Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric Carcinoma, a Phase 1b Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-10-18An Exploratory Phase II, Multicenter, Open-label Trial Evaluating the Activity and Tolerability of FK228 in Patients With Metastatic Renal Cell Carcinoma That is Progressive Following or During Immunotherapy
-
CLINICAL_TRIALS study record update · 2019-09-11A Phase 1 Study of LY2940680 in Japanese Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2019-09-04Dose-intensified Image-Guided Fractionated Radiosurgery for Spinal Metastases (DOSIS)
-
CLINICAL_TRIALS study record update · 2019-09-04Multicenter Study of Cryoablation for Palliation of Painful Bone Metastases
-
CLINICAL_TRIALS study record update · 2019-08-28Multicenter Study of Metastatic Lung Tumors Targeted by Interventional Cryoablation Evaluation
-
CLINICAL_TRIALS study record update · 2019-08-07Risk Adapted Free Flattering Filter Based Stereotactic Ablative Radiotherapy (Sabr) in Stage i Nsclc and Lung Metastases
-
CLINICAL_TRIALS study record update · 2019-06-24A Phase II, Multicenter Trial Aiming to Evaluate the Clinical Interest of a Monotherapy With BKM120 , a Phosphoinositide 3-kinase (PI3K) Inhibitor in Patient With Metastatic Head and Neck Cancer Recurrent or Progressive Under Platin and Cetuximab-based Chemotherapy
-
CLINICAL_TRIALS study record update · 2019-04-16Multicenter, Open-label, Randomized Phase III Trial for Administration of Zoledronate to Breast Cancer Metastatic Patients With Non-symptomatic Bone Lesions
-
CLINICAL_TRIALS study record update · 2019-03-22The Palliative Radiotherapy And Inflammation Study: Palliative Radiotherapy of Bone Metastasis. Classification, Inflammatory Biomarkers, and Longitudinal Clinical Follow-up
-
CLINICAL_TRIALS study record update · 2019-03-15Hepatic Artery Infusion Gemcitabine and Floxuridine in Patients With Nasopharyngeal Carcinoma Liver Metastases
-
CLINICAL_TRIALS study record update · 2019-02-11Health System Intervention to Improve Communication About End-of-Life Care for Vulnerable Patients
-
CLINICAL_TRIALS study record update · 2019-01-08A Multinational, Randomized, Phase III Study of XELIRI With/Without Bevacizumab Versus FOLFIRI With/Without Bevacizumab As Second-line Therapy in Patients With Metastatic Colorectal Cancer
-
CLINICAL_TRIALS study record update · 2018-12-21A Multi-Center Study of Paclitaxel/Cyclophosphamide and High Dose Melphalan/Etoposide With Autologous Progenitor Cell Transplantation for the Treatment of Inflammatory Breast Cancer
-
CLINICAL_TRIALS study record update · 2018-12-05A Phase I/II Study of Combination of Proton Therapy With Immunotherapy in Multiple Metastases Cancer
-
CLINICAL_TRIALS study record update · 2018-10-15A Randomized Phase 2 Study of Two Radiation Dose Schedules of Stereotactic Body Radiotherapy (SBRT) to Lung Metastases < 5cm in Dimension
-
CLINICAL_TRIALS study record update · 2018-08-02Effects of CYP3A Inhibition by Clarithromycin on the Pharmacokinetics of LY2835219 and Its Metabolites in Cancer Patients
-
CLINICAL_TRIALS study record update · 2018-07-05Phase I Evaluation of Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in Patients Undergoing Pulmonary Metastasectomy
-
CLINICAL_TRIALS study record update · 2018-05-16A Phase 1b/2 Study With Gemcitabine and LY2157299 for Patients With Metastatic Cancer (Phase 1b) and Advanced or Metastatic Unresectable Pancreatic Cancer (Phase 2)
-
CLINICAL_TRIALS study record update · 2018-03-09Feasibility Study of Biomarker Development for Response Prediction by Large Scale DNA Mutational Analysis of Metastatic Lesions
-
CLINICAL_TRIALS study record update · 2018-03-06GCC 0901- A Phase II Study of Letrozole in Combination With Lapatinib Followed by an Addition of Everolimus in Postmenopausal Women With Advanced Endocrine Resistant Breast Cancer